Clinical Research Directory
Browse clinical research sites, groups, and studies.
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Sponsor: Sacramento Pediatric Gastroenterology
Summary
The purpose of this study is twofold. First, is to determine whether vancomycin is effective in the early treatment of Biliary Atresia (BA) and Primary Sclerosing Cholangitis (PSC), and if so, by what mechanism. Secondly, to characterize human intestinal microbial communities and their interactions with the host.
Official title: The Human Gastrointestinal Tract Microbiota in the Setting of Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Key Details
Gender
All
Age Range
2 Weeks - 40 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2010-07
Completion Date
2028-07
Last Updated
2016-11-15
Healthy Volunteers
Yes
Interventions
Oral Vancomycin
Oral Vancomycin is given to PSC or BA participants
Locations (1)
Sacramento Pediatric Gastroenterology
Sacramento, California, United States